Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone-based anesthetic combinations for elderly patients undergoing ERCP
ChiCTR2500103676Phase 4Completed
- Sponsor
- Affiliated Hospital of Shandong Second Medical University
- Start
- Jun 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxycodone, propofol, etomidate, dexmedetomidine and sufentanil in postoperative delirium (POD) and post-operative cognitive decline (POCD) (5 arms), sponsored by Affiliated Hospital of Shandong Second Medical University. Primary endpoints: Confusion Assessment Method score and Mini-Mental State Examination score. Started Jun 2025; status: completed.
02
Drugs
oxycodonepropofoletomidatedexmedetomidinesufentanil
03
Conditions
postoperative delirium (POD)post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2500103676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103676.